Comparison
1q44 Microdeletion Syndrome C4304540 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 1q44 Microdeletion Syndrome and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
1q44 Microdeletion Syndrome C4304540
A rare chromosomal abnormality affecting chromosome 1. Causes developmental delays, intellectual disability, and brain abnormalities. Management is supportive and symptom-focused.
14q11 2 Microduplication Syndrome C4749855
A rare genetic condition involving a small extra piece of chromosome 14. Features vary and may include developmental delays. Management focuses on supportive therapies and monitoring.
6 comparison axes
Onset
1q44 Microdeletion Syndrome C4304540
0-null
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
1q44 Microdeletion Syndrome C4304540
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
1q44 Microdeletion Syndrome C4304540
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
1q44 Microdeletion Syndrome C4304540
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
1q44 Microdeletion Syndrome C4304540
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
1q44 Microdeletion Syndrome C4304540
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
1q44-microdeletion-syndrome-C4304540 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q44 Microdeletion Syndrome C4304540 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as a core feature of 1q44 deletion. | May occur, but features are variable and not uniform. | Moderate |
| Intellectual disability | Described in the supplied source. | Not specifically established by the supplied data. | Moderate |
| Brain abnormality | Brain abnormalities are described. | Not established in the supplied description. | Moderate |
When to favor each condition
Choose 1q44 Microdeletion Syndrome C4304540 when
A confirmed deletion involving 1q44
The chromosomal finding, not symptoms alone, identifies this condition.
High
Severe neurodevelopmental presentation with reported brain abnormality
This pattern fits the supplied description, but confirmation is still required.
Moderate
Counseling after a deletion result
Management is supportive and symptom-focused.
High
Choose 14q11 2 Microduplication Syndrome C4749855 when
A confirmed extra copy at 14q11.2
The duplication defines the condition despite variable clinical features.
High
Variable developmental concerns without a deletion finding
The supplied phenotype is variable and may include delay.
Low
Planning follow-up after duplication detection
Supportive therapies and monitoring are the described approach.
Moderate
How key tests differ
| Test | 1q44 Microdeletion Syndrome C4304540 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or equivalent | Deletion involving 1q44. | Microduplication involving 14q11.2. | The genomic result distinguishes the conditions; clinical correlation is needed. |
| Standard karyotype | A microdeletion may not be visible. | A microduplication may not be visible. | A normal karyotype does not exclude either condition. |
| Brain imaging | Abnormalities are described, but exact findings are not specified. | Expected findings are not established here. | Imaging supports assessment but does not replace genetic diagnosis. |
Prognosis comparison
1q44 Microdeletion Syndrome C4304540
- Outcome
- A chronic congenital condition with potentially substantial developmental impact; exact prognosis is not established.
- Factors
- Reported severity, intellectual disability, brain abnormalities, and available supports.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- A chronic condition with variable and potentially milder impact; exact prognosis is not established.
- Factors
- Variable phenotype, developmental findings, and response to supportive care.
Time frame: Lifelong, with needs changing across development.
Precise genomic result, associated findings, therapies, and individual course.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Delay is described and severity is listed as severe. Delay may occur; overall severity is listed as moderate. Individual outcomes vary and are not fully established. |
| Cognitive difficulty | Intellectual disability is described. Not specifically established in the source. Do not infer cognitive outcome from the duplication alone. |
| Long-term support needs | Supportive, symptom-focused care is expected. Supportive therapy and monitoring are described. Neither description establishes specific complications or mortality. |
Patient education highlights
- HighGenetic confirmation
Symptoms overlap with many conditions; the specific chromosomal result determines the diagnosis.
- HighSupportive care
Care focuses on developmental, educational, and medical needs rather than a single disease-specific cure.
- MediumVariable presentation
Especially for 14q11.2 duplication, features may differ between people and require clinician review.